3-10249510-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014760.4(TATDN2):āc.310C>Gā(p.Arg104Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000621 in 1,609,258 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014760.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TATDN2 | NM_014760.4 | c.310C>G | p.Arg104Gly | missense_variant | 2/8 | ENST00000448281.7 | NP_055575.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TATDN2 | ENST00000448281.7 | c.310C>G | p.Arg104Gly | missense_variant | 2/8 | 1 | NM_014760.4 | ENSP00000408736.2 | ||
TATDN2 | ENST00000287652.8 | c.310C>G | p.Arg104Gly | missense_variant | 2/8 | 1 | ENSP00000287652.4 | |||
ENSG00000272410 | ENST00000437082.5 | n.139C>G | non_coding_transcript_exon_variant | 1/8 | 2 | ENSP00000402783.1 | ||||
ENSG00000272410 | ENST00000450534.1 | n.139C>G | non_coding_transcript_exon_variant | 1/8 | 2 | ENSP00000399689.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152226Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000164 AC: 4AN: 243568Hom.: 0 AF XY: 0.0000227 AC XY: 3AN XY: 132416
GnomAD4 exome AF: 0.00000618 AC: 9AN: 1457032Hom.: 0 Cov.: 31 AF XY: 0.00000966 AC XY: 7AN XY: 724780
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152226Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 30, 2024 | The c.310C>G (p.R104G) alteration is located in exon 2 (coding exon 1) of the TATDN2 gene. This alteration results from a C to G substitution at nucleotide position 310, causing the arginine (R) at amino acid position 104 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at